Restoration of insulin independence with pancreatic islet cell therapy would remove the risk of hypoglycemia from exogenous insulin. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".